● Recruiting

A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children

Condition: Myopia · Sponsor: Qilu Pharmaceutical Co., Ltd.

PhasePhase 3

Planned participants735

Who can joinAll sexes, 6 Years to 12 Years

Healthy volunteersNo

About this study

Efficacy and Safety Study of QLM3004 in Myopic Children

This description comes directly from the study's public registry record.

Talk to the study team

Zhenjiang Wang · 0531-55821369 · zhenjiang.wang@qilu-pharma.com

Always discuss trial participation with your own doctor first.

Locations (1)

The Affiliated Eye Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06151587